Meta-analysis by El-badawy et al. [4] and Gan et al. [17] also demonstrated that MSC and CD34+ HSC were the most successful and effective SCT approaches in the patients with insulin-dependent diabetes, while Hwang et al. [18] claimed that the SCT was not effective in treatment of T1DM. This evidence concerns the gene CD34 and type 1 diabetes mellitus.